Product
Biphasic Insulin Aspart 30
Aliases
biphasic insulin aspart 30, NovoMix® 30
2 clinical trials
4 indications
Indication
DiabetesIndication
Diabetes MellitusIndication
Type 1Indication
Type 2Clinical trial
Efficacy of Glycaemic Control of Biphasic Insulin Aspart (NovoMix® 30) or Insulin Detemir (Levemir®) in Patients With Type 1 or 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2008-09-01
Clinical trial
NovoMix® 30 (Biphasic Insulin Aspart 70/30) Titrate-to-target: An Observational Study of the Efficacy of NovoMix® 30 in Subjects With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets on OADsStatus: Completed, Estimated PCD: 2006-07-01